MX2009004983A - Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion. - Google Patents
Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.Info
- Publication number
- MX2009004983A MX2009004983A MX2009004983A MX2009004983A MX2009004983A MX 2009004983 A MX2009004983 A MX 2009004983A MX 2009004983 A MX2009004983 A MX 2009004983A MX 2009004983 A MX2009004983 A MX 2009004983A MX 2009004983 A MX2009004983 A MX 2009004983A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions containing
- production
- substituted pyrazoles
- pyrazoles
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La invención se refiere a nuevos compuestos químicos, particularmente a pirazoles sustituidos, a composiciones que los contienen, y a su uso como fármacos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0609812A FR2908409B1 (fr) | 2006-11-10 | 2006-11-10 | Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation |
PCT/FR2007/001851 WO2008065282A2 (fr) | 2006-11-10 | 2007-11-09 | Pyrazoles substituees, compositions les contenant, procede de fabrication et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009004983A true MX2009004983A (es) | 2009-05-22 |
Family
ID=38169388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009004983A MX2009004983A (es) | 2006-11-10 | 2007-11-09 | Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion. |
Country Status (40)
Country | Link |
---|---|
US (3) | US7989439B2 (es) |
EP (1) | EP2091920B1 (es) |
JP (1) | JP5538893B2 (es) |
KR (1) | KR20090083456A (es) |
CN (1) | CN101553473B (es) |
AR (1) | AR063638A1 (es) |
AU (1) | AU2007327423B2 (es) |
BR (1) | BRPI0718999A2 (es) |
CA (1) | CA2667846A1 (es) |
CL (1) | CL2007003251A1 (es) |
CO (1) | CO6190516A2 (es) |
CR (1) | CR10749A (es) |
CY (1) | CY1116000T1 (es) |
DK (1) | DK2091920T3 (es) |
DO (1) | DOP2009000088A (es) |
EA (1) | EA019454B1 (es) |
EC (1) | ECSP099312A (es) |
ES (1) | ES2528385T3 (es) |
FR (1) | FR2908409B1 (es) |
HK (1) | HK1137988A1 (es) |
HN (1) | HN2009000856A (es) |
HR (1) | HRP20150070T1 (es) |
IL (1) | IL198328A0 (es) |
MA (1) | MA30972B1 (es) |
MX (1) | MX2009004983A (es) |
MY (1) | MY147502A (es) |
NI (1) | NI200900078A (es) |
NO (1) | NO20091990L (es) |
NZ (1) | NZ576709A (es) |
PE (2) | PE20081162A1 (es) |
PL (1) | PL2091920T3 (es) |
PT (1) | PT2091920E (es) |
SI (1) | SI2091920T1 (es) |
SV (1) | SV2009003253A (es) |
TN (1) | TN2009000155A1 (es) |
TW (1) | TW200829556A (es) |
UA (1) | UA97965C2 (es) |
UY (1) | UY30707A1 (es) |
WO (1) | WO2008065282A2 (es) |
ZA (1) | ZA200903560B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7858323B2 (en) * | 2004-06-09 | 2010-12-28 | The Regents Of The University Of Michigan | Phage microarray profiling of the humoral response to disease |
FR2947546B1 (fr) * | 2009-07-03 | 2011-07-01 | Sanofi Aventis | Derives de pyrazoles, leur preparation et leur application en therapeutique |
UY33200A (es) * | 2010-01-26 | 2011-08-31 | Sanofi Aventis | Derivados de ácido 3-heteroaroilamino-propiónico sustituidos con oxígeno y su uso como productos farmacéuticos |
TWI523844B (zh) * | 2011-01-26 | 2016-03-01 | 賽諾菲公司 | 經胺基取代之3-雜芳醯基胺基-丙酸衍生物及其作為藥物之用途 |
CN102432639B (zh) * | 2011-09-30 | 2013-11-06 | 山东大学 | 1-(2-羟基-3-(苯氨基)丙基)-3-二茂铁基-1h-吡唑-5-甲酸乙酯化合物及其应用 |
SG11201502893WA (en) | 2012-11-02 | 2015-05-28 | Pfizer | Bruton's tyrosine kinase inhibitors |
CN107667092B (zh) * | 2015-03-25 | 2021-05-28 | 诺华股份有限公司 | 作为fgfr4抑制剂的甲酰化n-杂环衍生物 |
CN107619388A (zh) * | 2016-07-13 | 2018-01-23 | 南京天印健华医药科技有限公司 | 作为fgfr抑制剂的杂环化合物 |
CN107840842A (zh) | 2016-09-19 | 2018-03-27 | 北京天诚医药科技有限公司 | 炔代杂环化合物、其制备方法及其在医药学上的应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6878714B2 (en) * | 2001-01-12 | 2005-04-12 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
AU2002305260A1 (en) * | 2001-04-27 | 2002-11-11 | Vertex Pharmaceuticals Incorporated | Pyrazole derived kinase inhibitors |
KR20060003351A (ko) * | 2003-04-16 | 2006-01-10 | 아스트라제네카 아베 | 화합물 |
US20040220186A1 (en) * | 2003-04-30 | 2004-11-04 | Pfizer Inc. | PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease |
NZ544756A (en) * | 2003-07-22 | 2009-09-25 | Astex Therapeutics Ltd | 3,4-Disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators |
JP2008505167A (ja) * | 2004-07-05 | 2008-02-21 | アステックス、セラピューティックス、リミテッド | 医薬組成物 |
WO2006018662A2 (en) * | 2004-08-16 | 2006-02-23 | Prosidion Limited | Aryl urea derivatives for treating obesity |
WO2006070198A1 (en) * | 2004-12-30 | 2006-07-06 | Astex Therapeutics Limited | Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
CN101146533A (zh) * | 2005-01-21 | 2008-03-19 | 阿斯泰克斯治疗有限公司 | 吡唑激酶抑制剂和其它抗肿瘤剂的组合 |
AR052559A1 (es) * | 2005-01-21 | 2007-03-21 | Astex Therapeutics Ltd | Derivados de pirazol para inhibir cdk's y gsk's |
EP1683796A1 (en) * | 2005-01-24 | 2006-07-26 | Schering Aktiengesellschaft | Pyrazolopyridines, their preparation and their medical use |
FR2947546B1 (fr) * | 2009-07-03 | 2011-07-01 | Sanofi Aventis | Derives de pyrazoles, leur preparation et leur application en therapeutique |
-
2006
- 2006-11-10 FR FR0609812A patent/FR2908409B1/fr not_active Expired - Fee Related
-
2007
- 2007-11-08 TW TW096142249A patent/TW200829556A/zh unknown
- 2007-11-09 MY MYPI20091827A patent/MY147502A/en unknown
- 2007-11-09 DK DK07870263.6T patent/DK2091920T3/en active
- 2007-11-09 CA CA002667846A patent/CA2667846A1/fr not_active Abandoned
- 2007-11-09 CL CL2007003251A patent/CL2007003251A1/es unknown
- 2007-11-09 AU AU2007327423A patent/AU2007327423B2/en not_active Ceased
- 2007-11-09 ES ES07870263.6T patent/ES2528385T3/es active Active
- 2007-11-09 NZ NZ576709A patent/NZ576709A/en not_active IP Right Cessation
- 2007-11-09 PE PE2007001548A patent/PE20081162A1/es not_active Application Discontinuation
- 2007-11-09 JP JP2009535773A patent/JP5538893B2/ja not_active Expired - Fee Related
- 2007-11-09 PE PE2012000296A patent/PE20121152A1/es not_active Application Discontinuation
- 2007-11-09 UA UAA200905930A patent/UA97965C2/ru unknown
- 2007-11-09 EP EP07870263.6A patent/EP2091920B1/fr active Active
- 2007-11-09 MX MX2009004983A patent/MX2009004983A/es active IP Right Grant
- 2007-11-09 BR BRPI0718999-0A2A patent/BRPI0718999A2/pt not_active IP Right Cessation
- 2007-11-09 CN CN200780045533XA patent/CN101553473B/zh not_active Expired - Fee Related
- 2007-11-09 AR ARP070105002A patent/AR063638A1/es not_active Application Discontinuation
- 2007-11-09 WO PCT/FR2007/001851 patent/WO2008065282A2/fr active Application Filing
- 2007-11-09 ZA ZA200903560A patent/ZA200903560B/xx unknown
- 2007-11-09 PL PL07870263T patent/PL2091920T3/pl unknown
- 2007-11-09 KR KR1020097011936A patent/KR20090083456A/ko active IP Right Grant
- 2007-11-09 SI SI200731592T patent/SI2091920T1/sl unknown
- 2007-11-09 UY UY30707A patent/UY30707A1/es not_active Application Discontinuation
- 2007-11-09 EA EA200970472A patent/EA019454B1/ru not_active IP Right Cessation
- 2007-11-09 PT PT78702636T patent/PT2091920E/pt unknown
-
2009
- 2009-04-23 DO DO2009000088A patent/DOP2009000088A/es unknown
- 2009-04-23 IL IL198328A patent/IL198328A0/en unknown
- 2009-04-24 TN TNP2009000155A patent/TN2009000155A1/fr unknown
- 2009-04-24 CR CR10749A patent/CR10749A/es unknown
- 2009-05-05 EC EC2009009312A patent/ECSP099312A/es unknown
- 2009-05-06 NI NI200900078A patent/NI200900078A/es unknown
- 2009-05-07 SV SV2009003253A patent/SV2009003253A/es unknown
- 2009-05-07 CO CO09046036A patent/CO6190516A2/es active IP Right Grant
- 2009-05-08 US US12/437,618 patent/US7989439B2/en not_active Expired - Fee Related
- 2009-05-08 HN HN2009000856A patent/HN2009000856A/es unknown
- 2009-05-22 NO NO20091990A patent/NO20091990L/no not_active Application Discontinuation
- 2009-06-05 MA MA31959A patent/MA30972B1/fr unknown
-
2010
- 2010-03-26 HK HK10103174.0A patent/HK1137988A1/xx not_active IP Right Cessation
-
2011
- 2011-06-09 US US13/156,915 patent/US8410286B2/en not_active Expired - Fee Related
- 2011-06-09 US US13/156,947 patent/US8420824B2/en not_active Expired - Fee Related
-
2015
- 2015-01-20 HR HRP20150070TT patent/HRP20150070T1/hr unknown
- 2015-01-22 CY CY20151100068T patent/CY1116000T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1891004T3 (pl) | Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych | |
MY153915A (en) | Organic compounds | |
MX2009004983A (es) | Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion. | |
MX2011005934A (es) | Compuestos organicos. | |
SI1888541T1 (sl) | Benzo(d)izoksazol-3-il-aminske spojine in njihova uporaba kot ligandi vaniloidnega receptorja | |
MX2009003382A (es) | Derivados de sulfonamidas sustituidos. | |
MX2011009369A (es) | 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
MX2007003108A (es) | Compuestos imidazo-3-il-amina sustituidos y biciclicos. | |
MX2011011661A (es) | Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750. | |
JO2778B1 (en) | Certain vehicles, installations and methods | |
UA95644C2 (ru) | Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний | |
MX2009010047A (es) | Compuestos quimicos. | |
MY150542A (en) | Cmet inhibitors | |
MX2009010045A (es) | Compuestos quimicos. | |
WO2008046581A3 (de) | Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln | |
JO2770B1 (en) | Organic compounds | |
MX2012004780A (es) | Inhibidores de akt. | |
MX2009013354A (es) | Compuestos de triarilo y composiciones que los contienen. | |
MX2011008825A (es) | 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3. | |
TW200738627A (en) | Trialkylsilyl-indoles | |
MX2011008662A (es) | 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3. | |
MX2011009338A (es) | 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3. | |
SG158091A1 (en) | Imidazoazepinone compounds | |
MX2009010176A (es) | Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos. | |
MX2009000768A (es) | Lactamas macrociclicas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FG | Grant or registration |